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Abbreviations 
ANOVA, analysis of variance; 
FBS, fetal bovine serum; 
GCL, ganglion cell layer; 
IL-1β, interleukin-1 beta;  
INL, inner nuclear layer;  
IPL, inner plexiform layer;  
NMDA, N-Methyl-D-aspartate; 
NO, nitric oxide;  
OCT, optimal cutting temperature gel; 
ONL, outer nuclear layer; 
OPL, outer plexiform layer; 
PBS, phosphate-buffered saline;  
PFA, paraformaldehyde; 
PHO, photoreceptor layer;  
RGC, retinal ganglion cells; 
RT, room temperature; 
STZ, streptozotocin;  
TBS, tris-buffered saline; 
TBS-T, tris-buffered saline containing Tween-20; 
TNF-α, tumor necrosis factor alpha;  
TUJ-1, neuron-specific class III beta-tubulin. 
 
Abstract  
Diabetic retinopathy is a leading cause of vision loss and blindness. Disruption of 
axonal transport is associated with many neurodegenerative diseases and might also 
play a role in diabetes-associated disorders affecting nervous system. We investigated 
the impact of type 1 diabetes (2 and 8 weeks duration) on KIF1A, KIF5B and dynein 
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motor proteins in the retina. Additionally, since hyperglycemia is considered the main 
trigger of diabetic complications, we investigated whether prolonged exposure to 
elevated glucose could affect the content and distribution of motor proteins in retinal 
cultures. The immunoreactivity of motor proteins was evaluated by 
immunohistochemistry in retinal sections and by immunoblotting in total retinal extracts 
from streptozotocin-induced diabetic and age-matched control animals. Primary retinal 
cultures were exposed to high glucose (30 mM) or mannitol (osmotic control; 24.5 mM 
plus 5.5 mM glucose), for seven days. Diabetes decreased the content of KIF1A at 8 
weeks of diabetes as well as KIF1A immunoreactivity in the majority of retinal layers, 
except for the photoreceptor and outer nuclear layer. Changes in KIF5B 
immunoreactivity were also detected by immunohistochemistry in the retina at 8 weeks 
of diabetes, being increased at the photoreceptor and outer nuclear layer, and 
decreased in the ganglion cell layer. Regarding dynein immunoreactivity there was an 
increase in the ganglion cell layer after 8 weeks of diabetes. No changes were detected 
in retinal cultures. These alterations suggest that axonal transport may be impaired 
under diabetes, which might contribute to early signs of neural dysfunction in the retina 
of diabetic patients and animal models. 
 
Key words  
Diabetes; retina; axonal transport; kinesin; dynein. 
 
1. Introduction  
Diabetic retinopathy is the most common microvascular complication of diabetes 
mellitus and is a leading cause of vision loss and blindness among working-age adults 
in Western countries. However, increasing evidence has shown that the neural 
components of the retina are also affected (Antonetti et al., 2006). Alterations in 
electroretinograms in diabetic patients and animals, and loss of colour and contrast 
sensitivity are early signs of neural dysfunction in the retina (Roy et al., 1986, Daley et 
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al., 1987, Sakai et al., 1995), demonstrating that the neural retina can be also affected 
by this disease.  
Neurons are highly polarized cells, with long axons, which constitute a major challenge 
to the movement of proteins, vesicles, and organelles between cell bodies and 
presynaptic sites. To overcome this, neurons possess specialized transport machinery 
consisting of cytoskeletal motor proteins (kinesins and dynein) generating directed 
movements along cytoskeletal tracks. Axonal transport motor proteins require ATP 
demands, which implies the localization of functional mitochondria along the axons. 
Mobile mitochondria can become stationary or pause in regions that have a high 
metabolic demand and can move again rapidly in response to physiological changes. 
Defects in mitochondrial transport are implicated in the pathogenesis of several major 
neurological disorders (Sheng and Cai, 2012). Axonal transport is therefore crucial to 
maintain neuronal viability, and any impairment in this transport may play a role in the 
development or progression of several diseases (De Vos et al., 2008). 
A decrease in the levels of mRNAs encoding for neurofilament proteins was found in 
the dorsal root ganglia of streptozocin-induced diabetic rats (Mohiuddin et al., 1995). 
Additionally, slow axonal transport of neurofilament and microtubule components is 
reduced, leading to a decrease in axonal caliber (Medori et al., 1988). These evidences 
suggest that deficits in axonal transport may contribute to neuronal changes observed 
in diabetes in neural tissues. To our knowledge, only a few studies have evaluated the 
effect of diabetes on axonal transport in the retina and most of them have focused in 
studying fluoro-gold labelling in retinal ganglion cells (RGCs) (Zhang et al., 1998, Ino-
Ue et al., 2000, Zhang et al., 2000). Despite these evidences, the impact of diabetes in 
motor proteins (kinesins and dynein) in the retina has not been addressed. 
Nevertheless, potential changes in their content and distribution might underlie some 
changes already observed in axonal transport in the retina and visual pathway under 
diabetic conditions (Zhang et al., 2000, Fernandez et al., 2012).  
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Previously, we found that diabetes changes the levels of several synaptic proteins in 
retinal nerve terminals, with no changes in total retinal extracts, suggesting that axonal 
transport of those proteins may be impaired in diabetes (Gaspar et al., 2010a). 
Hyperglycemia is considered the main pathogenic factor for the development of 
diabetic complications. We found that high glucose leads to an accumulation of 
vesicular glutamate transporter-1, syntaxin-1 and synaptotagmin-1 at the cell body in 
hippocampal cell cultures, further suggesting that axonal transport of these proteins to 
nerve terminals might be affected under hyperglycemic conditions (Gaspar et al., 
2010b). Recently, we showed that mRNA levels and the content of kinesin motor 
proteins are altered in the hippocampus of diabetic rats (Baptista et al., 2013). We also 
demonstrated that high glucose leads to changes in the immunoreactivity of motor 
proteins and synaptic proteins specifically in the axons of hippocampal neurons further 
suggesting that anterograde axonal transport may be impaired in the hippocampus 
(Baptista et al., 2013). These changes detected in the hippocampus of diabetic rats 
lead us to check whether similar changes could also be occurring in the retina under 
diabetes. Therefore, in this work, we aimed to study the effect of diabetes and also high 
glucose per se (prolonged exposure for 7 days), mimicking hyperglycemic conditions, 
on the content and distribution of the motor proteins KIF1A (kinesin that transports 
synaptic vesicle precursors), KIF5B (kinesin involved in mitochondrial transport and in 
the transport of synaptic vesicle precursors and membrane organelles) and dynein 
(motor protein for retrograde axonal transport) in diabetic animals and primary rat 
retinal cell cultures. Since motor proteins need ATP to carry cargoes along the axons, 
the distribution of mitochondria was also analyzed in retinal neural cell cultures 
exposed to high glucose. 
 
2. Material and methods 
2.1 Animals  
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Male Wistar rats (Charles River Laboratories), eight weeks-old, were randomly 
assigned to control or diabetic groups. All procedures were in agreement with the EU 
Directive 2010/63/EU for animal experiments. Diabetes was induced with a single 
intraperitoneal injection of streptozotocin (STZ; 65 mg/kg, freshly dissolved in 10 mM 
sodium citrate buffer, pH 4.5) (Sigma, St. Louis, MO, USA). Hyperglycemic status 
(blood glucose levels exceeding 250 mg/dl) was confirmed two days after STZ 
injection with a glucometer (Elite, Bayer, Portugal). Before sacrifice, rats were 
weighted and blood samples were collected for measurement of glucose. Diabetic rats 
and age-matched controls were anesthetized with halothane and then sacrificed, 2 and 
8 weeks after the onset of diabetes. 
 
2.2 Preparation of total retinal extracts 
The eyes of diabetic and age-matched control animals were enucleated and placed in 
cold phosphate-buffered saline (PBS, in mM: 137 NaCl, 2.7 KCl, 10 Na2HPO4, 1.8 
KH2PO4, pH 7.4, at 4ºC). Retinas were dissected and lysed in RIPA buffer (50 mM 
Tris–HCl, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1% Triton X-100, 0.5% DOC, 0.1% 
SDS, 1 mM DTT) supplemented with complete miniprotease inhibitor cocktail tablets 
and phosphatase inhibitors (10 mM NaF and 1 mM Na3VO4). Then, lysates were 
sonicated and centrifuged at 16,000 x g for 10 min at 4ºC. The supernatant was 
collected and stored at -80ºC until use. 
 
2.3 Primary cultures of rat retinal neural cells 
Retinal cell cultures were obtained from the retinas of 3–5 days-old Wistar rats as 
previously described (Santiago et al., 2006). Cells were plated at a density of 2.0x106 
cells per cm2 on poly-D-lysine substrate (0.1 mg/ml) and were maintained at 37ºC in a 
humidified incubator with 5% CO2/air. The concentration of glucose in control 
conditions was 5 mM. After 2 days in culture, cells were incubated with 25 mM D-
glucose (30 mM final concentration, with 5 mM from culture medium) or 25 mM D-
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mannitol (plus 5 mM glucose from culture medium), which was used as an osmotic 
control, and maintained for additional 7 days in culture (nine days in culture). 
 
2.4 Immunohistochemistry in retinal sections 
2.4.1 Preparation of cryosections 
Rats from each experimental group were deeply anesthetized with ketamine/xylazine 
and intracardially perfused with 0.1 M PBS, followed by 4% paraformaldehyde (PFA) in 
0.1 M PBS. The eyes were enucleated, washed in ice-cold PBS and fixed in 4% PFA in 
PBS for 1 h. The cornea was removed and the posterior segments were fixed in 4% 
PFA in PBS for an additional period of 5 h. Tissue samples were transferred to 20% 
sucrose buffer overnight at 4°C for cryoprotection and then were embedded in OCT 
(Shandon Cryomatrix, Shandon, USA). The blocks were stored in a deep freezer (-
80ºC) until use. Transverse sections with 12 µm were obtained on a cryostat (Leica 
CM3050S, Nussloch, Germany) at -20ºC. The cryosections were then collected on 
gelatin-coated glass slides and allowed to air dry for 1 h. Retina sections were then 
stored at -20ºC for later use. 
 
2.4.2 Immunohistochemistry 
For immunostaining, frozen sections were placed 45 min at room temperature RT. After 
thawing, the sections were fixed in cold acetone (-20ºC) during 10 min and 
subsequently hydrated 3 times in PBS, during 10 min each time, to remove OCT. 
Sections were permeabilized with 0.25% Triton X-100 in PBS, for 30 min, and blocked 
with 5% fetal bovine serum (FBS) in PBS, for 30 min. Then, sections were incubated 
with primary antibodies (listed in Table 1) at 4°C,  overnight, in a humid atmosphere, to 
avoid tissue dehydratation. After washing in PBS, a conjugated secondary antibody 
plus DAPI (1:5,000), to stain cell nuclei, were added for 1 h in the dark, at RT. After 
washing the sections in PBS, coverslips were mounted over the retinal sections using 
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glycergel (Dako mounting medium). Stained sections were observed with a laser 
scanning confocal microscope LSM 710 META (Zeiss, Germany).  
 
2.4.3 Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end labeling 
(TUNEL) assay  
TUNEL assay was performed in retinal sections according to the manufacturer 
instructions (Promega, USA). Nuclei were counterstained with DAPI (1:5,000) and the 
sections were mounted using Dako glycergel mounting medium. TUNEL-positive cells 
were counted at the GCL, and expressed as an average from the four retinal sections 
per condition normalized to the retina length. Representative images were acquired 
with a laser scanning confocal microscope (Zeiss LSM 710). 
 
2.4.4 Immunofluorescence quantification of retinal slices 
A semi-quantitative determination of immunoreactive product densities at the level of 
the retinal layers was performed using ImageJ 1.42 software. In order to determine the 
fluorescence intensity of motor proteins (KIF1A, KIF5B and dynein), slides containing 
retinal slices from control and diabetic groups were blind coded. Sections from each 
immunohistological experiment, consisting of samples from control and diabetic group, 
were captured under identical conditions. Typically, four retinal sections from each 
animal were used for quantification. Random window sampling within the layers was 
carried out for quantification so that the intrinsic variability in the expression was 
appropriately quantified. To remove tissue background, for each image, a negative 
control (primary antibody omitted) of coverslipped tissue at the similar location was 
imaged, and background values were then subtracted from the experimental values, 
which were expressed in fluorescence arbitrary units (AU). Product densities were 
averaged across the four sections from each retina and expressed as mean 
percentage change; the percentage change across the control and diabetic groups was 
obtained and expressed as mean ± SEM. Although the intensity of staining varied from 
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one experiment to another, within a single experiment the application of primary and 
secondary antibodies, exposure times and acquisition image settings were uniform. 
This approach provides a measurement of the relative percentage change among 
control and diabetic groups based on the staining density in a given retinal layer.  
 
2.5 RNA extraction and cDNA synthesis 
Total RNA from the two retinas from control and diabetic rats was isolated using the 
RNeasy Mini Kit (Qiagen, Germany), as previously described (Baptista et al., 2013). 
 
2.6 Primer design and Quantitative real time polymerase chain reaction 
Primer design and evaluation for quantitative real time polymerase chain reaction 
(qRT-PCR) was performed exactly as previously described (Baptista et al., 2013). Final 
primer sequences and amplicon lengths are shown in Table 2.  
qRT-PCR and data analysis were performed also as previously described (Baptista et 
al., 2013). The data analysis was based on 5 independent biological replicates per 
group. The results were expressed as the mean ± SEM. Data were analyzed by the 
unpaired Student's t-test (IBM SPSS Statistics, USA) to determine differences in gene 
expression between groups. Differences were considered statistically significant when 
p<0.05. 
 
2.7 Preparation of extracts of cultured retinal cells 
Cells were rinsed twice with ice-cold PBS and then lysed with RIPA buffer 
supplemented with complete miniprotease inhibitor cocktail tablets and phosphatase 
inhibitors. Lysates were incubated on ice for 30 min and then centrifuged at 16,100 x g 
for 10 min at 4ºC. The supernatant was collected and stored at -80ºC until use.  
 
2.8 Western blot analysis 
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The protein concentration of each sample was determined by the bicinchoninic acid 
(BCA) protein assay (Pierce Biotechnology, Rockford, IL, USA). The samples were 
denaturated by adding 6x concentrated sample buffer (0.5 M Tris, 30% glycerol, 10% 
SDS, 0.6 M DTT, 0.012% bromophenol blue) and heating for 5 min at 95ºC. Equal 
amounts of protein were loaded into the gel and proteins were separated by sodium 
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE), using 6-8% gels. 
Proteins were transferred electrophoretically to PVDF membranes (Millipore, Billerica, 
Massachusetts, USA) and then the membranes were blocked with 5% low-fat milk in 
Tris-buffered saline (137 mM NaCl, 20 mM Tris-HCl, pH 7.6) containing 0.1% Tween-
20 (TBS-T) for 1 h at room temperature. Membranes were incubated with primary 
antibodies (listed in Table 1) overnight at 4ºC. After washing for 1 h in TBS-T with 0.5% 
low-fat milk, the membranes were incubated with an anti-mouse or anti-goat alkaline 
phosphatase-linked IgG secondary antibody (1:10,000; GE Healthcare, 
Buckinghamshire, UK) in TBS-T with 1% low-fat milk for 1 h at room temperature. After 
washing for 1 h in TBS-T with 0.5% low-fat milk, the membranes were processed for 
protein detection using the enhanced chemifluorescence substrate (ECF; GE 
Healthcare). Fluorescence was detected on an imaging system (Thyphoon FLA 9000, 
GE Healthcare) and the digital quantification of bands immunoreactivity was performed 
using ImageQuant 5.0 software (Molecular Dynamics, Inc., Sunnyvale. CA, USA). The 
membranes were then reprobed and tested for β-actin immunoreactivity (1:5,000; 
Sigma) or β-III tubulin (1:5,000; Covance) to prove that similar amounts of protein were 
applied to the gels.  
 
2.9 Immunocytochemistry 
Retinal cell cultures were washed with PBS and fixed with 4% PFA and 4% sucrose for 
10 min at RT. Cells were then washed and permeabilized with 1% Triton X-100 in PBS 
for 10 min at RT. Non-specific binding was prevented incubating cells with 5% 
FBS/0.2% Tween-20 in PBS for 20 min. Cells were incubated with the primary 
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antibodies (listed in Table 1) for 2 h at RT. After incubation, cells were rinsed with PBS 
and incubated with the secondary antibodies for 1 h at RT in the dark. The nuclei were 
stained with DAPI (1:5,000). Upon rinsing with PBS, the coverslips were mounted on 
glass slides using Dako Fluorescence mounting medium (Dako, Denmark). 
Preparations were visualized in a laser scanning confocal microscope LSM 710 META 
(Zeiss, Germany). Quantitative analysis of immunocytochemistry data was performed 
using ImageJ 1.42 software as previously described (Baptista et al., 2013). 
 
2.10 Statistical analysis 
Statistical comparisons between diabetic animals and respective age-matched controls 
were performed using the unpaired Student’s t-test. Variance analysis was not 
undertaken since the effect of age on the content of motor proteins was not the aim of 
this study. Thus, gels were always loaded with samples from age-matched animals and 
not from animals with different ages. Statistical significance for the analysis of retinal 
cell cultures protein content was determined by using one-way ANOVA, followed by 
Dunnett’s post hoc test. Quantitative analysis of immunofluorescence data was 
performed using ImageJ and statistical analysis between control and diabetic animals 
was performed using the unpaired Student’s t-test. Differences were considered 
significant for p<0.05. 
 
3. Results  
3.1 Animal body weight and glucose blood levels 
Animal body weight assessed prior the induction of diabetes was similar between the 
two groups (255.7±3.5 g for control animals and 253.4±3.4 g for diabetic group), as 
well as the blood glucose levels (89.1±1.4 mg/dl for controls and 86.7±5.7 mg/dl for 
diabetic group). The average weight and blood glucose levels for both diabetic and 
aged-matched control rats at the time of death are given in Table 3. A marked 
impairment in weight gain occurred in diabetic rats comparing to age-matched controls 
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in all time points analyzed. Diabetic animals also presented significantly higher blood 
glucose levels when compared to age-matched controls. 
 
3.2 Diabetes decreases the protein levels of KIF1A in total retinal extracts 
The impact of diabetes in motor proteins involved in axonal transport in the retina is 
unknown. We analyzed the mRNA levels and protein content of KIF1A, KIF5B, and 
dynein in total retinal extracts from diabetic animals and age-matched controls. At 2 
weeks of diabetes, no significant changes were detected in the mRNA levels or protein 
content of KIF1A and KIF5B. However, a significant decrease was found at 8 weeks of 
diabetes in KIF1A protein levels in total retinal extracts (reduction to 69.6±6.0% of 
control), whereas KIF5B levels remained unchanged. Moreover, no significant 
differences were detected between diabetic and age-matched control animals in dynein 
mRNA levels or protein content at 2 and 8 weeks of diabetes (Figure 1). 
 
3.3 Diabetes decreases KIF1A immunoreactivity  
Immunoreactivity of KIF1A across the retinal layers was also analyzed in diabetic and 
age-matched control rats. No significant changes were observed in KIF1A 
immunoreactivity in the retina at 2 weeks of diabetes, compared to control. However, at 
8 weeks of diabetes there was a significant decrease in KIF1A immunoreactivity in the 
majority of retinal layers (Figure 2). A reduction to 52.7±11.3%, 48.1±9.2%, 
51.4±10.5% and 38.7±9.5% was detected in the outer plexiform layer (OPL), the inner 
nuclear layer (INL), the inner plexiform layer (IPL) and the ganglion cell layer (GCL), 
respectively. 
 
3.4 Diabetes changes KIF5B immunoreactivity in the retina 
No differences were found in the content of KIF5B in total retinal extracts or in the 
distribution of KIF5B at 2 weeks of diabetes. However, by immunohistochemistry it was 
detected a significant increase in KIF5B immunoreactivity in the outermost retinal 
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layers at 8 weeks of diabetes (Figure 3), namely at the outer and inner segments of 
photoreceptor layer (PHO) and at the outer nuclear layer (ONL), to 166.1±14.3% and 
138.7±13.2%, respectively, comparing to age-matched controls. Conversely, a 
significant decrease in the GCL to 76.9±8.6%, comparing to age-matched controls, was 
detected at 8 weeks of diabetes (Figure 3). 
 
3.5 Diabetes increases the dynein immunoreactivity at GCL 
As mentioned before, in total retinal extracts, dynein levels remained similar to those 
found in control animals at 2 and 8 weeks of diabetes (Figure 1). Nevertheless, by 
immunohistochemistry, it was detected a significant increase (122.1±9.2% comparing 
to age-matched controls) in dynein immunoreactivity in the GCL at 8 weeks of diabetes 
(Figure 4). 
 
3.6 High glucose does not change KIF1A, KIF5B, and dynein immunoreactivity in 
retinal cultures 
Hyperglycemia is considered the main cause of diabetes complications, triggering 
various processes that may induce cell dysfunction. KIF1A and KIF5B are motor 
proteins that transport cargoes from the cell body to the synapse, whereas dynein is 
responsible for retrograde axonal transport. Exposure of cultured retinal cells to 
elevated concentrations of D-glucose (30 mM) or D-mannitol (24.5 mM + 5.5 mM 
glucose), for 7 days, did not induced changes in total protein content of KIFA, KIF5B 
and dynein (Figure 5A). Additionally, the morphology of retinal neurons was analyzed 
by immunocytochemistry using a TUJ-1 (neuron-specific class III β-tubulin) antibody. 
High glucose and mannitol did not induce any alteration in neuronal morphology 
(Figure 5B). The immunoreactivity of KIF1A, KIF5B and dynein, as well as the 
fluorescence of mitotracker (fluorescent dye that stains mitochondria in live cells) also 
showed that high glucose and mannitol did not induce any changes when compared to 
control (Figure 5B). Nevertheless, other factors besides hyperglycemia, such as the 
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increase in the levels of pro-inflammatory mediators, may possibly contribute for the 
changes detected in motor proteins in the retina of diabetic animals. In fact, 
inflammatory stimuli can induce changes in the levels of motor proteins in cultured 
retinal neural cells (Figure S1). KIF1A levels significantly decreased after exposure to 
IL-1β (10 ng/ml; reduction to 64.9±8% of control) or LPS (1 µg/ml; reduction to 
76.6±7% of control) for 72h (Figure S1). 
 
 
4. Discussion 
In the current study, we evaluated the impact of diabetes and elevated glucose on key 
proteins involved in axonal transport in retinal cells. We show that diabetes alters the 
content of KIF1A and the distribution of KIF1A, KIF5B and dynein along retinal layers at 
8 weeks of diabetes, suggesting that anterograde and retrograde transport mediated by 
these motor proteins may be impaired.  
Previously, we have demonstrated that the mRNA levels and content of KIF1A and 
KIF5B motor proteins are altered in the hippocampus of diabetic rats. In this study, we 
found no correlation between protein and mRNA expression levels of KIF1A in the 
retina, indicating that the changes detected at protein level appear not to be caused by 
changes at the transcript level. Because there are various levels of post-transcriptional 
and post-translational regulation, the alterations in the transcript levels do not always 
correlate with the alterations observed at the protein levels, which is the case for KIF1A 
at least at these time points analyzed.  
In a preceding study we have found a decrease in the content of several synaptic 
proteins important for neurotransmission in retinal nerve terminals at 2 and/or 8 weeks 
of diabetes (Gaspar et al., 2010a, Baptista et al., 2011). Since anterograde axonal 
transport is responsible for carrying proteins to nerve terminals, which are involved in 
synaptic transmission, the decrease in the content of synaptic proteins in nerve 
terminals may be a consequence of deficits in their transport. In fact, in cones lacking 
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KIF3A (kinesin present in photoreceptors), changes in photoreceptor properties occur, 
showing the importance of kinesin in the visual pathway (Avasthi et al., 2009). 
Moreover, trafficking of membrane proteins involved in phototransduction to the outer 
segments is impaired, resulting in progressive cone degeneration and absence of a 
photopic electroretinogram (Avasthi et al., 2009). Another study in the retina showed 
that, after 24 and 72 h of intravitreal injection of NMDA, an early elevation of KIF5B 
protein levels in the retina occurs, whereas a significant decrease is observed in the 
optic nerve, thus suggesting that a depletion of KIF5B precedes axonal degeneration of 
the optic nerve in NMDA-induced neurotoxicity (Kuribayashi et al., 2010). Moreover, it 
was found a deficit in the anterograde transport from the retina to the superior 
colliculus, 6 weeks after the induction of diabetes with STZ (Fernandez et al., 2012). 
Possibly, similar changes as those we detected in our diabetic model, namely in the 
content of KIF1A and distribution of KIF1A and KIF5B in the retinal layers at 8 weeks of 
diabetes, may also be occurring at 6 weeks of diabetes which may contribute therefore 
to the deficits observed in the anterograde transport from the retina to the superior 
colliculus. 
In the opposite direction, there is the retrograde axonal transport system, which 
transports, among other molecules, neurotrophic factors that influence steady-state 
activities in the cell body. It was previously reported a progressive deficit in the 
retrograde axonal transport, mainly in large axons, that is evident 1 month after 
diabetes induction and is not associated with RGC loss (Ino-Ue et al., 2000). In an 
experimental model of glaucoma, the expression of dynein light chain in RGC is 
downregulated, which could contribute to neuronal dysfunction and apoptosis (van 
Oterendorp et al., 2011). On the other hand, it was demonstrated that dynein heavy 
chain (chain that contains the site of ATP hydrolysis and is the force-generating part of 
the protein) accumulates at the optic nerve head with experimental intraocular pressure 
elevation in the rat, supporting the hypothesis that disrupted axonal transport in RGC 
may be involved in the pathogenesis of glaucoma (Martin et al., 2006). Here, we 
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studied the 74 kDa dynein intermediate chain subunit that forms a bridge between the 
heavy chain and dynactin subunits, which bind microtubules and the cargo to be 
transported. We found that there is an increase in dynein immunoreactivity in the GCL 
of diabetic rats after 8 weeks duration. This increase in dynein immunoreactivity might 
be due to impairments at microtubule network level and/or impairment in dynein motor 
function, leading to an accumulation of dynein. An alternative explanation is that dynein 
is being trapped at the cell body due to lack of recycling back to the axon terminals by 
kinesin. It has been shown that kinesin and dynein motors can co-localize on vesicular 
cargoes (Hendricks et al., 2010, Encalada et al., 2011). Also, it was demonstrated that 
there are direct interactions between kinesin motors and components of the 
cytoplasmic dynein complex (Deacon et al., 2003, Ligon et al., 2004). Importantly, 
kinesin-dependent transport is required to deliver dynein to the plus ends of 
microtubules in the periphery (Zhang et al., 2003, Baumann et al., 2012). When axonal 
transport is blocked by ligature, kinesin accumulates in the proximal site, whereas 
dynein accumulates both proximally and distally, consistent with the fact that dynein is 
firstly transported down the axon in order to initiate active transport back to the cell 
body. The opposite does not occur, since kinesin motors do not accumulate on the 
distal side of a ligature, and so dynein does not transport kinesins as transport cargos 
(Li et al., 2000). These observations are a possible explanation for the decrease in 
KIF5B immunoreactivity in the GCL. Likely KIF5B levels decrease at the cell bodies of 
RGCs compromising anterograde transport. Consequently, dynein might be trapped at 
the cell body due to lack of recycling back to the axon terminals by kinesin, which might 
be the cause of the increase in the dynein immunoreactivity at the GCL after 8 weeks 
of diabetes. Regarding the KIF5B accumulation at the inner/outer segments and cell 
bodies of photoreceptors, it may be due to the imbalance in protein degradation and 
synthesis or to axonal transport deficit due to changes in tracks (e.g. microtubules) (De 
Vos et al., 2008). Alternatively, an overexpression of KIF5B may function as a 
compensatory mechanism as an attempt of the system to re-establish the protein 
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levels. It is important to highlight that the changes reported in motor proteins are not 
due to changes or loss in neuronal structure. We evaluated several neural elements of 
the retina to control for cell loss or cellular changes. Firstly, we performed a TUNEL 
assay in retinal slices from 8 weeks diabetic rats. In the majority of retinal slices, we did 
not find any TUNEL-positive cell. As it can be observed in Figure S2 A, in a few retinal 
slices of diabetic rats we detected just one TUNEL-positive cell. Regarding counts of 
DAPI-stained cells at the level of the GCL, we did not find any changes after 8 weeks 
of diabetes. Neural apoptosis in the GCL has already been reported on the whole-
mounted diabetic rat retina (Barber et al., 1998). Barber and colleagues showed that an 
increase in the frequency of apoptosis occurred in whole-mounted rat retinas after 1, 3, 
6, and 12 months of diabetes. They also reported a decrease in the RGC number and 
inner plexiform layer thickness, which occurs after 7.5 months of STZ-induced diabetes 
in rats (Barber et al., 1998), whereas Kusari et al. reported a loss of RGCs at 4 weeks 
of STZ injection (Kusari et al., 2007). Moreover, an increase in the number of apoptotic 
RGCs was also demonstrated after 3 months of diabetes (Seigel et al., 2006). In our 
hands, we only detected one TUNEL-positive cell in the RGC layer in just one slide and 
detected TUNEL-positive cells in the ONL in just a few slices, after 8 weeks of 
diabetes, indicating that in our model there is not a pronounced cell death in diabetic 
retinas at 8 weeks of diabetes. Besides TUNEL-positive cells and DAPI-stained cell 
counts, we also did not detect any changes in the number of Brn3a-positive cells 
(ganglion cell marker) after 8 weeks of diabetes (Figure S2 B). No significant changes 
were detected in beta-III-tubulin immunoreactivity at this timepoint as well (Figure S2 
C). 
Regarding potential macroglial changes, by analyzing GFAP immunoreactivity we did 
not find any significant changes in the levels of this protein neither by western blotting 
nor by immunohistochemistry (Figure S3 A). Barber et al. described that after 8 weeks 
of diabetes, there was a reduction in GFAP immunoreactivity in astrocytes and 
increased GFAP immunoreactivity in small groups of Muller cells (Barber et al., 2000). 
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In our retinal slices, immunoreactivity was largely confined to the ganglion cell layer 
and no differences in the immunoreactivity of GFAP were detected between control 
and diabetic animals. Concerning microglial cells, we found that there was an 
increased number of Iba-1-positive microglial cells in the retina of diabetic animals 
(21.7±1.9 for diabetic animals whereas age-matched controls presented 17.0±0.7 Iba-
1-positive cells per mm of retina). Moreover, some cell bodies of Iba-1-positive cells 
appeared larger, with an amoeboid morphology, and with shorter processes in the 
retinas of diabetic animals (see inset in Figure S3 B), consistent with early microglia 
activation, as already had been described (Zeng et al., 2000, Barber et al., 2005, 
Gaucher et al., 2007) .  
Previously, we demonstrate that the mRNA levels and content of KIF1A and KIF5B 
motor proteins are altered in the hippocampus of diabetic rats. Together, with the 
results presented in this study, we can suggest that diabetes may affect axonal 
transport at central nervous system, possibly by changing the transport of cargoes 
(namely synaptic vesicles and mitochondria) since their transport is mediated by these 
kinesins and dynein, and ultimately contribute to neural changes underlying diabetic 
encephalopathy and retinopathy.  
Since hyperglycemia is considered the main factor underlying the development of 
diabetic complications, we evaluated whether prolonged exposure to high glucose per 
se, which simulates hyperglycemic conditions, could change the content of proteins 
involved in axonal transport in primary retinal cultures. Moreover, since KIF5 motors 
are responsible for the axonal transport of mitochondria, the fluorescence of 
mitotracker, a mitochondrial probe, was also evaluated. A decreased number of 
mitochondria in axons will likely decrease ATP supply to molecular motors, thus 
leading to decreased anterograde and retrograde movement of mitochondria and 
vesicles. High glucose did not induce any significant changes in the content and 
general distribution of motor proteins and mitochondria in retinal cultures. However, in 
this study we were not able to quantify the immunoreactivity of motor proteins 
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specifically in retinal neurons since we used mixed cultures and we were not able to 
isolate axons for quantification. Moreover, the neurons in these cultures are not viable 
in low density cultures, therefore we cannot completely discard the possibility that 
changes may be occurring specifically at the axonal level as we previously 
demonstrated in hippocampal neurons (Baptista et al., 2013). 
On the other hand, we cannot exclude the hypothesis that other factors, besides 
hyperglycemia, such as the lack of insulin or the increase in the levels of pro-
inflammatory mediators, may contribute for the changes in motor proteins detected in 
the retina of diabetic animals. In fact, in sensory neurons, the loss of insulin-dependent 
neurotrophic support may contribute to mitochondrial membrane depolarization, thus 
establishing a link between insulin and mitochondrial dysfunction in diabetic neuropathy 
(Fernyhough et al., 2003). Furthermore, retinal neurons depend on insulin receptor 
activity for survival (Barber et al., 2001). Long-term instability in retinal insulin signalling 
may impair insulin-dependent anabolic activities such as protein synthesis in the retina 
(Chihara, 1981) and increased cell death (Reiter and Gardner, 2003), suggesting that 
insulin signalling provides neurotrophic actions in the retina. Therefore, diabetic 
retinopathy may result in part from neurotrophin deficiency (Whitmire et al., 2011), 
similarly to peripheral neuropathy. In this study, retinal cells were cultured in the 
presence of fetal bovine serum, which makes impossible to address the question of the 
lack of insulin using these cell cultures. In fact, in the past, we tried to culture retinal 
cells without serum, using B27 supplement, but cultures did not differentiate properly 
and cells died. 
Several evidences indicate that diabetic retinopathy also has characteristics of a low-
grade chronic inflammatory disease and therefore, inflammation may also be a factor 
contributing to changes in axonal transport in diabetes. Increased production of 
cytokines, such as interleukin-1 beta (IL-1β) and tumor necrosis factor alpha (TNF-α), 
up-regulation of cyclooxygenase-2, increased expression of adhesion molecules and 
increased leukocyte adhesion and vascular permeability (Miyamoto et al., 1999, Carmo 
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et al., 2000, Kowluru et al., 2003) have been demonstrated in the retina of diabetic 
animals. Additionally, in the retinas of STZ-induced diabetic rats the levels of IL-1β are 
also increased (Carmo et al., 1999, Kowluru and Odenbach, 2004, Gerhardinger et al., 
2005, Krady et al., 2005). Previously, it was shown that TNF-α induces perinuclear 
clustering of mitochondria in L929 cells. This clustering of mitochondria was 
microtubule-dependent and mimicked by immunoinhibition of conventional kinesin, 
therefore suggesting that TNF-α-induced mitochondrial clustering is caused by 
impaired kinesin-mediated transport of mitochondria (De Vos et al., 1998). Moreover, it 
was shown that TNF receptor-1 induces activation of kinase pathways, resulting in 
hyperphosphorylation of kinesin light chain and inhibition of kinesin activity (De Vos et 
al., 2000). In hippocampal neurons, nitric oxide released from activated microglia 
inhibits directed axonal movement of synaptic vesicle precursors containing 
synaptophysin and synaptotagmin (Stagi et al., 2005), and exposure of hippocampal 
neuronal cultures to TNF-α induces the dissociation of KIF5B from tubulin in axons and 
inhibits axonal transport of mitochondria and synaptophysin by reducing the mobile 
fraction via JNK (Stagi et al., 2006). Therefore, inflammatory cytokines may affect 
axonal transport motors and consequently contribute to the previous detected changes 
in synaptic proteins in the retina (Gaspar et al., 2010a, Baptista et al., 2011). Moreover, 
as an indication that inflammatory stimuli can induce changes in the levels of motor 
proteins, incubation of cultured retinal neural cells with IL-1β or LPS significantly 
decreased KIF1A levels, putting forward a possible explanation for the changes in 
KIF1A observed in the retinas of diabetic rats (Figure S1).  
 
5. Conclusions 
In summary, our data demonstrate that diabetes leads to changes in KIF1A, KIF5B and 
dynein motor proteins, which may contribute to impairments in anterograde and 
retrograde axonal transport and consequently to neuronal dysfunction in the retina. The 
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changes observed may be due to insulin deficiency or inflammation rather than 
hyperglycemia, or to a synergistic combination of these factors. 
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Figure Legends  
Figure 1. Diabetes decreases KIF1A protein content in the retina. The mRNA 
levels of KIF1A, KIF5B and dynein were assessed by RT-PCR (A), whereas protein 
levels were analyzed by immunoblotting (B) in total retinal extracts obtained from 
control and STZ-induced diabetic animals (2 and 8 weeks of diabetes). Representative 
Western blots are presented above the graphs, with the respective loading controls (β-
actin or β-III tubulin), to confirm that identical amounts of protein from control and 
diabetic samples were loaded into the gel. The results are expressed as percentage of 
age-matched controls, and data are presented as mean ± SEM of 4-7 animals. 
*p<0.05, significantly different from control as determined by the unpaired Student’s t-
test. 
 
Figure 2. Diabetes decreases KIF1A immunoreactivity along retinal layers. (A) 
The distribution of KIF1A was evaluated in retinas (retinal slices) isolated from control 
and STZ-induced diabetic animals (2 and 8 weeks of diabetes) by 
immunohistochemistry. Magnification 400x; Scale bar: 50 µm. White arrows indicate 
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the retinal layers where significant differences were detected comparing to age-
matched controls. (B) The immunoreactivity of KIF1A was quantified in each retinal 
layer by ImageJ. The results are expressed as percentage of age-matched controls, 
and data are presented as mean ± SEM of at least 6 animals per condition. ***p<0.001, 
significantly different from control as determined by the unpaired Student’s t-test. 
 
Figure 3. Diabetes alters the distribution of KIF5B in the retina. (A) The distribution 
of KIF5B was evaluated in retinas (retinal slices) isolated from control and STZ-induced 
diabetic animals (2 and 8 weeks of diabetes) by immunohistochemistry. Magnification 
400x; Scale bar: 50 µm. White arrows: significantly different from control. (B) The 
immunoreactivity of KIF5B was quantified in each retinal layer by ImageJ. The results 
are expressed as percentage of age-matched controls, and data are presented as 
mean ± SEM of at least 6 animals per condition. *p<0.05, **p<0.01, ***p<0.001, 
significantly different from control as determined by the unpaired Student’s t-test. 
 
Figure 4. Diabetes induces alterations in dynein immunoreactivity at GCL. (A) 
The distribution of dynein was evaluated in retinas (retinal slices) isolated from control 
and STZ-induced diabetic animals (2 and 8 weeks of diabetes) by 
immunohistochemistry. Magnification 400x; Scale bar: 50 µm. (B) The immunoreactivity 
of dynein was quantified in each retinal layer by ImageJ. The results are expressed as 
percentage of age-matched controls, and data are presented as mean ± SEM of at 
least 7 animals. ***p<0.05, significantly different from control as determined by the 
unpaired Student’s t-test. 
 
Figure 5. High glucose does not affect the content and distribution of KIF1A, 
KIF5B and dynein in retinal neural cell cultures. Cultured retinal cells were 
incubated with 25 mM D-glucose (final concentration 30 mM) or 25 mM D-mannitol 
(plus 5 mM glucose), which was used as an osmotic control, and maintained for 
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additional 7 days in culture. The concentration of glucose in control conditions was 5 
mM. (A) The protein levels of KIF1A, KIF5B and dynein were analyzed by western 
blotting. Representative images of protein immunoreactive bands are presented above 
the graphs, with the respective loading control (β-actin or β-III tubulin). The 
densitometry of each band was analyzed and the results are expressed as percentage 
of control ± SEM, of five independent experiments. Regarding total protein content, 
statistical significance was determined by using ANOVA, followed by Dunnett’s post 
hoc test. Differences were considered significant for p<0.05. (B) The protein levels and 
distribution of TUJ-1, KIF1A, KIF5B and dynein in the culture was analyzed by 
immunocytochemistry, as well as the intensity of fluorescence of mitotracker. 
Magnification 630x; Scale bar: 50 µm.  
 
Supplementary Data 
Figure Legend 
Figure S1. Inflammatory stimuli induce changes in the content of KIF1A in retinal 
neural cell cultures. Cultured retinal cells were exposed to IL-1β (10 ng/ml) or 
lipopolysaccharide (LPS; 1µg/ml) for 24h or 72h. The protein levels of KIF1A, KIF5B 
and dynein were analyzed by western blotting. Representative images of protein 
immunoreactive bands are presented above the graphs, with the respective loading 
control (β-actin). The densitometry of each band was analyzed and the results are 
expressed as percentage of control ± SEM, of five independent experiments. Statistical 
significance was determined by using ANOVA, followed by Dunnett’s post hoc test. 
*p<0.05, **p<0.01, significantly different from control. 
 
Figure S2. Diabetes does not induce a widespread retinal degeneration after 8 weeks 
of diabetes. (A) Cell death was evaluated in retinal slices of 8 weeks diabetic rats by 
the TUNEL assay and by DAPI-stained cells counts at the GCL. TUNEL-positive cells 
can be identified by green fluorescence (white arrow), whereas DAPI-stained cells at 
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the GCL are in blue (yellow arrow). (B) Diabetes does not induce changes in the 
number of Brn3a-positive cells (red arrow) in the retina after 8 weeks of diabetes. (C) 
Diabetes does not induce changes in the immunoreactivity of beta-III tubulin in the 
retina after 8 weeks of diabetes. The protein levels of beta-III tubulin were analyzed by 
western blotting. Representative images of protein immunoreactive bands are 
presented above the graph. The results are expressed as percentage of age-matched 
controls, and data are presented as mean ± SEM of 8 animals. The distribution of beta-
III tubulin was also evaluated in retinas (retinal slices) isolated from control and STZ-
induced diabetic animals (8 weeks of diabetes) by immunohistochemistry and no 
significant differences were detected in beta-III tubulin immunoreactivity. Statistical 
significance was determined by using the unpaired Student’s t-test.  
 
Figure S3. Diabetes increases the number of Iba-1-positive cells in the retina after 8 
weeks of diabetes, but not of GFAP-immunoreactivity. (A) The protein levels of GFAP 
were analyzed by western blotting. Representative images of protein immunoreactive 
bands are presented above the graph. The results are expressed as percentage of 
age-matched controls, and data are presented as mean ± SEM of 5 animals. Statistical 
significance was determined by using the unpaired Student’s t-test. The quantification 
of GFAP immunoreactivity (in red) was evaluated in retinas (retinal slices) isolated from 
control and STZ-induced diabetic animals (8 weeks of diabetes) by 
immunohistochemistry. (B) Diabetes increases the number of Iba-1-positive cells in the 
retina after 8 weeks of diabetes. In some retinal slices some microglial cells present an 
amoeboid-like morphology contrasting with the ramified microglia morphology in control 
retinas. The distribution of Iba-1 positive cells (in red) was evaluated in retinas (retinal 
slices) isolated from control and STZ-induced diabetic animals (8 weeks of diabetes) by 
immunohistochemistry. 
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Table 1. List of primary antibodies used.
Primary Antibody Sample Antibody Dilution Protein (µg) Source
Total Extracts Retina 1:1,000 40
Total Extracts Primary cultures 1:1,000 40
Immunocytochemistry 1:50 _
Immunohistochemistry 1:50 _
Total Extracts Retina 1:2,000 10
Immunohistochemistry 1:100 _
Total Extracts Primary cultures 1:2,000 20
Immunocytochemistry 1:100 _
Total Extracts Retina 1:2,000 20
Immunohistochemistry 1:100 _
Total Extracts Primary cultures 1:2,000 40
Immunocytochemistry 1:100 _
Total Extracts Retina 1:5,000 10
Immunocytochemistry 1:1,000 _
Total Extracts Retina 1:5,000 10
Immunocytochemistry 1:400 _
Rabbit anti-Iba-1 Immunocytochemistry 1:1,000 _ Wako
Mouse anti-Brn3a Immunocytochemistry 1:200 _ Chemicon
CovanceRabbit anti-TUJ-1
Mouse anti-GFAP Calbiochem
BD BiosciencesMouse anti-KIF1A
Abcam
Abcam
Goat anti-KIF5B
Santa CruzGoat anti-KIF1A
Mouse anti-Dynein
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Table 2. Primer sequences.
Gene Forward primer (5’-3’) Reverse primer (5’-3’) Amplicon size (bp)
Reference genes
GAPDH GACTTCAACAGCAACTCC GCCATATTCATTGTCATACCA 105
HPRT ATGGGAGGCCATCACATTGT ATGTAATCCAGCAGGTCAGCAA 77
YWHAZ CAAGCATACCAAGAAGCATTTGA GGGCCAGACCCAGTCTGA 76
Target genes
KIF1A CATTAGTTAGTGGCGTTGA TACCTGGAGGCATTAGAAA 91
KIF5B GTGATGATTGCGTCCAAG CTTCTTTGCACAATCGTTG 90
DYNEIN TTCTGGCGTAGTCCTATT ACACCACATCTCAAGTCT 104
DYNEIN - dynein cytoplasmic 1 intermediate chain.
GAPDH - glyceraldehyde-3- phosphate dehydrogenase; 
HPRT - human hypoxanthine phosphoribosyltransferase;
YWHAZ  - tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide;
KIF1A - kinesin family member 1A; 
KIF5B - kinesin family member 5B; 
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Weight (g) Blood Glucose (mg/dL)
Control 319.5±5.4 102.3±3.5
Diabetic 233.2±8.5*** 377.4±21.2***
Control 394.6±16.7 89.9±2.9
Diabetic 245.7±13.6*** 488.9±38.5***
2 Weeks
8 Weeks
Measurements were made immediately before the sacrifice of the animals. ***p<0.001.
Table 3. Average weight and blood glucose levels of diabetic and aged-matched control rats.
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Highlights:  
• Kinesin and dynein motor proteins are altered in the retinas of diabetic rats. 
• High glucose per se did not lead to changes in motor proteins in retinal 
neurons. 
• Other factors, like inflammation, may contribute for the alterations in motor 
proteins. 
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